ZNF202 Inhibitors

Chemical inhibitors of ZNF202 can act through various mechanisms to disrupt its function, primarily targeting its zinc finger domains, which are essential for DNA binding. 2-Mercaptoethanol, for example, interferes with disulfide bonds within these domains, inducing conformational changes that inhibit ZNF202's ability to interact with DNA. Similarly, 1,10-Phenanthroline and PDTC operate by chelating zinc ions, depriving ZNF202 of its structural cofactor necessary for maintaining its DNA-binding conformation. TPEN, a more selective chelator, also sequesters zinc ions, and this depletion results in the functional inhibition of ZNF202 by destabilizing its crucial zinc finger motifs.

Further disrupting the zinc fingers of ZNF202, compounds like Clotrimazole and Ebselen exert their inhibitory effects by binding directly to the protein's zinc finger domains. Clotrimazole alters the protein's conformation, impeding its DNA interaction, while Ebselen's interaction with cysteine residues has the potential to modify the structural integrity of the zinc finger domains. Diethyldithiocarbamate follows a similar path of zinc chelation, detaching the metal ions critical for ZNF202's function. The covalent modification of cysteine residues within ZNF202 by 3,5-Dibromo-4-hydroxybenzaldehyde disrupts its DNA binding activity. Aurintricarboxylic acid stands out as it inhibits the interaction between nucleic acids and ZNF202, thereby preventing the protein from binding to its target DNA sequences. The inhibition by Clioquinol and Pyrithione zinc is also attributed to their capacity to chelate zinc, but with additional implications on zinc homeostasis, which can affect the structural competency of ZNF202's zinc finger domains. Lastly, Phenylarsine oxide binds to the vicinal thiols, likely perturbing the thiolate coordination of zinc within the zinc fingers of ZNF202, leading to its functional inhibition.